Ginkgo Bioworks Holdings, Inc. Logo

Ginkgo Bioworks Holdings, Inc.

A cell programming platform offering R&D services for pharma, agriculture, food, and chemicals.

DNA | US

Overview

Corporate Details

ISIN(s):
KYG8354H1267 (+2 more)
LEI:
Country:
United States of America
Address:
27 DRYDOCK AVENUE, 2210 BOSTON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Ginkgo Bioworks Holdings, Inc. is a synthetic biology company that operates a leading horizontal platform for cell programming. Its core mission is to make biology easier to engineer, enabling customers to program cells with the ease of programming computers. The company's platform leverages high-throughput automation, proprietary software, artificial intelligence, and an extensive biological codebase to design, build, and test custom organisms for its partners. Ginkgo provides flexible, end-to-end R&D services to solve challenges across diverse markets, including pharmaceuticals, agriculture, food and nutrition, and specialty chemicals, facilitating the development of novel and more sustainable products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ginkgo Bioworks Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ginkgo Bioworks Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ginkgo Bioworks Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Inotiv, Inc. Logo
CRO providing nonclinical drug discovery, research models, and analytical services for life sciences.
United States of America
NOTV
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France
ALINT
Intellia Therapeutics, Inc. Logo
Developing curative CRISPR/Cas9 genome editing therapies for severe genetic disorders.
United States of America
NTLA
InterDigital, Inc. Logo
Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.
United States of America
IDCC
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea
287840
Inventage Lab Inc. Logo
Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.
South Korea
389470
Investeko Spolka Akcyjna Logo
Offers environmental consulting, R&D, and design for commercial eco-innovations.
Poland
IVE
IQVIA HOLDINGS INC. Logo
Global provider of analytics, tech, and clinical research for life sciences and healthcare.
United States of America
IQV
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden
ISOFOL

Talk to a Data Expert

Have a question? We'll get back to you promptly.